Find the Right Market Report
Search thousands of industry reports, market insights, and research studies in one place.
Search thousands of industry reports, market insights, and research studies in one place.
Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
20 November 2025
Announcement Augurex Life Sciences Corp., a key player in the establishment of autoimmune-related diagnostics, have introduced its upcoming 14-3-3eta test to soon ramp the official stage. The 14-3-3e...
18 November 2025
Announcement Hemostemix Inc. has ticked and represented its major key points from its Grand Rounds presentation held on 12th November at the University of Florida (UF, Gainesville), vascular team. T...
17 November 2025
Announcement Niagen Bioscience, Inc., the leading global authority on NAD+ (nicotinamide adenine dinucleotide) with an aim on the science of healthy ageing, have shared dedicated results from the be...
17 November 2025
Announcement Neurogene Inc., a clinical-level leading company built to introduce life-changing, transformative genetic medicines to families and patient groups suffering from rare neurological disea...
14 November 2025
Announcement Dare Bioscience, Inc. is an intention-driven, accelerated biotech company completely targeting covering the gap between real-world solutions and promising science to improve women’...
14 November 2025
Announcement Galvanize Therapeutics Inc., a leading marketing pro medical technology company featuring pulsed electric field (PEF) therapies for chronic lung disease and oncology, opted for the onlin...
13 November 2025
Announcement AN2 Therapeutics, Inc., a leading biopharmaceutical company specialising in small molecule therapeutics with its comprehensive boron chemistry platform, has fixed a research collaborati...
12 November 2025
Announcement Innate Pharma SA proudly declared that they have received clearance by the US Food and Drug Administration (FDA) for the confirmatory Phase 3 protocol for lacutamab in cutaneous T-cell ...
11 November 2025
Announcement The major IAVI’s Lassa virus (LASV) vaccine candidate findings from a first-in-human, Phase 1 clinical trial are now on the page of New England Journal of Medicine. The published ...
11 November 2025
Announcement Eli Lilly’s amylin agonist, eloralintide, successfully showed 20% of weight loss in its mid-stage study that marked the course for the phase 3 trial. The analyst, William Blair, c...
Speak with a healthcare analyst about your research, consulting, or platform needs.